Kringle Pharma (4884) · InitiativeRestated
Controls Through the Compliance and Risk Management Committee
First written in FY2020. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Regular Risk Deliberations by the Risk Management CommitteeA theme 149 companies write about · 0 as a headwind · 131 as a tailwind
82 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 149 companies compared. The sentences above are computed from all 149.Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「リスクが顕在化した場合は迅速かつ的確に対応することにより被害を最小限に食い止め、再発を防止することを目的に「リスクマネジメント規程」、「コンプライアンス規程」を制定し、コンプライアンス・リスクマネジメント委員会により統制を図っております。」
規程とコンプライアンス・リスクマネジメント委員会によるリスク把握、予防、発生時対応、再発防止の体制を継続している。 - FY2020First statedAnnual report
「We have established Risk Management Regulations and Compliance Regulations and exercise control through the Compliance and Risk Management Committee. The purpose is to identify, collect, assess and prevent complex and diversified risks centrally, respond quickly and appropriately when risks materialize, minimize damage and prevent recurrence.」
The company has established a system for identifying and preventing risks, responding when they occur and preventing recurrence through its regulations, committee and reporting to the board of directors.